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Abstract.  Fifteen peptides,  ranging  in length from 6 
to 31  amino acids and corresponding in sequence to 
portions of the major phenobarbital-inducible  form of 
rat liver cytochrome P-450 (P-450 PB-4), were previ- 
ously synthesized chemically and used to prepare site- 
specific rabbit antibodies (Frey,  A. B., D.  J. Waxman, 
and G. Kreibich,  1985, J.  Biol.  Chem., 
260:15253-15265).  The antipeptide antibodies were 
affinity purified using Sepharose resins derivatized 
with the respective peptides and  14 preparations were 
obtained that in an ELISA assay showed affinities to 
immobilized P-450 judged to be adequate for binding 
studies on intact rat liver microsomes.  The binding of 
these antibodies to rough microsomes from the livers 
of phenobarbital treated rats was assessed using ~25I-la- 
beled IgG and by immunoelectron microscopy employ- 
ing protein A-gold as a marker.  It was found that 
many of the antibodies bound to the cytoplasmic sur- 
face of the membrane but none bound to the luminal 
face of ruptured or inverted microsomal vesicles or to 
contaminating  membranes of other organelles present 
in the preparations.  These observations eliminate pre- 
viously proposed models for the transmembrane dispo- 
sition of P-450 that postulate the existence of multiple 
transmembrane domains and the exposure of several 
polar segments of the polypeptide on the luminal  side 
of the membrane.  The fact that an antibody raised to 
the first 31  residues of P-450 bound well to the 
purified P-450 but very poorly to rough microsomes, 
whereas an antibody to a peptide comprising residues 
24-38 showed relatively strong binding to intact 
microsomes, is consistent with the proposal that the 
amino terminal  segment of P-450 extending approxi- 
mately to residue 20 is embedded in the phospholipid 
bilayer and the immediately following segment is ex- 
posed on the cytoplasmic surface of the membrane. 
All these results favor a model in which the 
cytochrome P-450 molecule is largely exposed on the 
cytoplasmic surface of the endoplasmic reticulum 
membrane to which it is anchored by its short amino 
terminal hydrophobic segment. 
I 
N the hepatocyte,  cytochromes P-450 represent a family 
of hemoprotein monooxygenases that are located in en- 
doplasmic reticulum  (ER) 1 membranes and function in 
the metabolism of a wide variety  of endogenous and exog- 
enous  substrates  (see  Lu  and  West,  1980; Adesnik  and 
Atchison,  1985; Black and Coon, 1986). The ER membrane 
provides  a  framework  that  facilitates  the  interaction  of 
cytochrome P-450 molecules with a specific NADPH cyto- 
chrome  P-450  reductase  that  transfers  electrons  to  the 
cytochrome P-450 heme moiety. Both cytochrome P-450 and 
its reductase  are integral  membrane proteins  partially  em- 
bedded in the phospholipid bilayer. As is the case with many 
other ER membrane proteins  (Kreibich  et al.,  1983), the 
reductase  is  anchored  in  the  membrane  only by a  small 
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hydrophobic  segment  and  the bulk of the protein can be 
released from the membrane by mild proteolytic digestion 
(Black and Coon, 1982; Masters and Okita,  1980). The large 
exposure of the reductase on the cytoplasmic face of the ER 
membrane indicates that the portion of the cytochrome P-450 
molecule that interacts with it must also be exposed on that 
surface. 
Two closely related forms of cytochrome P-450 (PB-4 and 
PB-5) (Waxman and Walsh, 1982; Ryan et al., 1982a) that ac- 
cumulate to high levels in the liver of rats treated with pheno- 
barbital (PB) have been widely studied.  Direct experimental 
evidence for the cytoplasmic exposure of functionally impor- 
tant domains of these P-450 polypeptides is provided by the 
finding  that  the  enzymatic  activity associated  with  these 
molecules is completely inhibited when anti-P-450 antibod- 
ies are added to intact  microsomes (Thomas  et al.,  1977; 
Ryan et al.,  1982b). The extensive exposure of cytochrome 
P-450 on the cytoplasmic  surface of the ER membrane has 
also been inferred from the sensitivity  of the protein to pro- 
teolytic digestion of intact microsomes (Nilsson et al., 1978; 
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catalyzed  iodination  (Welton  and  Aust,  1974; Rodriguez 
Boulan et al.,  1978). However, unlike the situation with the 
reductase and other ER membrane proteins (Kreibich et al., 
1983), it has not been possible to recover from microsomes 
treated  with  proteases  large  globular  fragments  of cyto- 
chrome P-450 that are spectroscopically recognizable and 
catalytically active (Nilsson et al.,  1978). 
The complete amino acid sequence of the phenobarbital- 
induced cytochrome P-450 of rabbit liver has been deter- 
mined  and,  on the basis  of a  hydropathy analysis of this 
sequence, models have been proposed in which the polypep- 
tide spans the lipid bilayer several times and specific portions 
of the molecule are exposed on the luminal face of the ER 
(Heinemann and Ozols,  1982; Tarr et al.,  1983).  Previous 
immunocytochemical studies (Matsuura  et al.,  1978, 1979, 
1983)  have  shown  extensive binding  of antibodies  raised 
against  the  complete  cytochrome  P-450  molecule to  the 
cytoplasmic surface of the ER membrane, but no labeling 
was observed on the luminal face of the membrane. Although 
these studies suggest that no sizable portion of cytochrome 
P-450 is exposed on the luminal side of the membrane, it 
must be recognized that, in general, polyclonal antisera pri- 
marily contain antibodies that recognize a small number of 
dominant epitopes and therefore are not effective probes to 
localize all parts of a protein molecule. We have therefore 
used site-specific antibodies raised against 15 synthetic pep- 
tides (Frey et al., 1985) that correspond to selected domains 
of the rat liver cytochrome P-450 PB-4, in binding and im- 
munocytochemical studies, to probe for the exposure of the 
respective antigenic domains on the cytoplasmic or luminal 
side of the membranes of rat liver rough microsomes. Our 
results support a model for P-450 in which the molecule is 
bound to the membrane only by a small amino terminal an- 
chor,  whereas the rest of the molecule is  exposed on the 
cytoplasmic surface of the membrane. 
Materials and Methods 
PB Treatment 
Young male Sprague-Dawley rats (50-75 g) were purchased from Charles 
River Breeding Labs (Wilmington, MA) and fed ad libitum on laboratory 
chow.  PB,  dissolved  in  physiological  saline,  was  administered  by  in- 
traperitoneal injections (100 mg/kg body wt) once a  day for 4  d.  Control 
animals were left untreated. 
Cell Fractionation  Procedures 
PB-treated animals were fasted for  12-18 h before death by decapitation. 
Livers were excised and perfused with ice-cold 0.25 M  sucrose and liver 
microsomes were prepared (Adelman et al.,  1973) in solutions containing 
0.1 mM phenylmethylsulfonyl fluoride (Lewis and Sabatini,  1977).  Rough 
microsomes, separated from smooth microsomes on a  discontinuous su- 
crose gradient, were washed once by sedimentation in 0.25 M  sucrose and 
stored at -70°C in the same medium. Protein was measured by a modifica- 
tion (Markwell et al.,  1978) of the method of Lowry et al.  (1951) and by 
Coomassie Blue binding (Bradford,  1976), using BSA as a  standard. 
Preparation of  Antibodies against 
Cytochrome P-450 PB-4 
A  P-450 preparation (P-450 PB) containing the major PB-inducible iso- 
zymes of rat liver, cytochromes P-450 PB-4 (80%) and P-450 PB-5 (20%), 
was purified from the livers of immature rats as described previously (West 
et al.,  1979; Waxman and Walsh,  1982;  Frey et al.,  1985).  Cytochrome 
P-450 PB-4 and PB-5, which have only a  13 amino acid difference in 491 
residues (Suwa et al., 1985), are indistinguishable  by Ouchterlony immuno- 
diffusion procedures (Ryan et al., 1982a, b). Antibodies against cytochrome 
P-450 PB were raised in rabbits and IgG  fractions of the antisera were 
purified by ammonium sulfate fractionation (Frey et al.,  1985). 
Synthesis of Site-specific Anti-P-450 
PB-4 Peptide Antibodies 
A hydropathy profile (Kyte and Doolittle,  1982) for P-450 PB-4 was calcu- 
lated from the published amino acid sequence (Fujii-Kuriyama et al., 1982; 
Yuan et al., 1983) using a scan length of nine amino acids. Regions of pre- 
dominant hydrophobic and hydrophilic character were selected for peptide 
synthesis. 
15 peptides (indicated in Fig. 1) were chemically synthesized (Merrifield, 
1963) as previously described (Frey et al., 1985).  Before injection into rab- 
bits the peptides were conjugated to either Keyhole Limpet Hemocyanin or 
hen lysozyme as carder proteins. The site-specific rabbit antipeptide anti- 
bodies were affinity purified on Sepharose 4B derivatized with the respec- 
tive peptide (Frey et al.,  1985). 
ELISA Test  for the Binding of  Affinity-purified 
Antipeptide Antibodies to Purified Cytochrome 
P-450 
The preparation of microplates for the ELISA test has been previously de- 
scribed (Frey et al.,  1985).  Each well contained cytochrome P-450 PB (0.5 
I.tg) or  1 mg BSA as immobilized antigen and the antipeptide antibody 
diluted with PBS containing 0.1% BSA. The plates were incubated for I h 
at 37°C. After washing, the amount of fixed antibody was measured through 
the binding of peroxidase-conjugated affinity-purified goat anti-rabbit lgG 
(1  h  incubation at 37°C) and subsequently reacted with 2-2'azino-di-C3- 
ethyl benzthiazolinesulfonic acid (30 rain at room temperature). The con- 
tent of each well was removed, diluted to a final volume of 1 ml, and the 
A4o5 was measured. An A405 of 0.11 was obtained from the BSA control and 
this value was subtracted from those obtained for wells containing the in- 
dividual antibodies. The binding of each antibody to P-450 PB was graded 
as  :-,  <I).!5  A~5;  +,  0.15-0.3 A4o5; ++,  0.3-0.6 A40~, and  +++,  >0.6 
A405- 
12~I-Labeling of the Antipeptide Antibodies 
Affinity-purified antipeptide antibodies were iodinated using 1,3,4,6-tetra- 
chloro-3a,6a-diphenylglycouril (Iodo-Gen,  Pierce  Chemical  Co.,  Rock- 
ford,  IL)  and  [t25I]NaI  (carrier-free,  100 mCi/mmol; New England Nu- 
clear,  Boston, MA).  Aliquots (0.01 ml) of Iodo-Gen dissolved in CH3C1 
(1 mg/ml) were dried in the bottom of glass test tubes with a gentle stream 
of N2. The tubes were then rinsed five times with PBS (pH 7.4) and the an- 
tibody solutions were added.  [J25I]NaI neutralized immediately before use 
with an equal volume of 0.1 N HC1 was then added to each antibody sample. 
The reaction was allowed to proceed for 45 rain on ice with occasional mix- 
ing.  Unincorporated  [125I]NaI  was  removed  by  chromatography  on  a 
Sephadex G-25 column using PBS as elution buffer. Incorporation of ~25I 
in the excluded fraction was determined by gamma counting after TCA 
precipitation. The specific activities of the iodinated IgGs ranged from 1.3 
to  10.6 ×  103 cpm/pmol.  Solutions of the m25I-labeled antibodies in 30% 
glycerol were stored at  -20°C. 
Binding of  Radiolabeled Antibodies 
to Rough Microsomes 
Aliquots (0.5 ml) of a microsome suspension (2 mg/ml) in a buffer contain- 
ing 0.1 M sodium phosphate buffer (pH 7.5), 0.16 M NaCI, and 0.25 M su- 
crose were incubated for 1 h at 0°C with increasing amounts of ~25I-labeled 
antipeptide IgGs (1-15), with pre-absorbed anti-7 antibody, or pre-immune 
IgG. The microsomes were recovered by sedimentation (30 min at 40,000 
rpm in a rotor;  model SW56,  Beckman Instruments, Inc., Fullerton, CA) 
through a 20%  sucrose cushion containing 0.5 M  NaCI. Radioactivity in 
the membrane pellets was determined by gamma counting. 
Conjugation  of Colloidal Gold Particles to Protein A 
Colloidal gold particles,  10 nm in diameter, were purchased from Janssen 
Life Sciences Products (Beerse, Belgium). The pH of the colloidal gold was 
adjusted  to  7.4  with  0.01 M  K2CO3  and  the  conjugation of protein  A 
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F/~ur~ L  Location of the 15 antigenic poptides within the sequence 
of rat liver cytochrome P-450 PB-4. The sequences corresponding 
to the  15  peptides that were  synthesized and used to obtain site- 
specific antibodies are underlined and numbered sequentially be- 
ginning at the amino terminus. The amino acid sequence of cyto- 
chrome P-450 PB-4 is that deduced from the nucleotide sequence 
of a cDNA clone (Fujii-Kuriyama et al.,  1982; Yuan et al.,  1983). 
(Sigma Chemical Co., St. Louis, MO) to the colloidal gold particles was 
carried out as described (Horisberger and Rosset, 1977; Roth et al., 1978) 
with the modification that three to four times more protein A gold than was 
necessary for the stabilization of the colloidal gold suspension was used. 
After 1 rain, polyethylene  glycol 20,000 M (0.1% final concentration; Fisher 
Scientific Co.,  Pittsburgh,  PA)  was added.  The  suspension was  gently 
shaken for 15 min, sedimented at 60,000 g for 1 h at 4°C, resuspended in 
PBS  containing 0.1%  polyethylene glycol 20,000  M,  and centrifuged at 
60,000 g for 1 h or at 6,700 g overnight. The sediment, resuspended in PBS 
containing 0.03%  polyethylene glycol 20,000  M and 0.02%  Na azide, was 
stored at 4"C. Before use the suspension was diluted 1:3 with PBS contain- 
ing 50 pg/ml BSA and 0.03 % polyethylene glycol 20,000  M. 
lmmunogold Labeling of  Rat Liver Rough Microsomes 
The rough microsome suspension was diluted to  10  mg protein/ml and 
0.1 ml aliquots were used. The microsomes were recovered by sedimenta- 
tion for 2 min in an Eppendorf microcentrifuge (model 5412; Brinkmann 
Instruments Co., Westbury, NY) and resuspended in PBS. The resuspended 
microsomes were fixed for 2 h at 4°C with 3 vol of PLP (3 % paraformalde- 
hyde, 0.075 M lysine-HCl, 0.01 M Na-m-periodate, 0.037 M Na phosphate 
buffer, pH 7.4 [Mclean and Nakane,  1974]). The fixed microsomes were 
sedimented and resuspended in PBS containing 10 mM glycine, incubated 
for 10 min in this medium to block free aldehyde groups, and sedimented. 
This procedure was repeated three times and the fixed samples were finally 
resuspended in 0.1 ml PBS. The anti-P-450 IgG or the afffinity-purified an- 
tipeptide antibody (25-250 ttg) was then added in 0.1 ml of PBS. The sam- 
pies were incubated with shaking overnight at 4°C. The microsomes were 
sedimented, resuspended in PBS, and washed three times in the medium 
to remove unbound antibody. Controls were incubated with pre-immune 
rabbit IgG instead of the specific antibody. For an additional control, the 
anti-P-450 and antipeptide antibodies (150 pg/ml) were incubated overnight 
at 4°C with rough microsomes (3 mg) to remove the reactive antibodies. 
The microsomes were then sedimented in an Eppendorf centrifuge and the 
supernatants  were  used  in  the  immunolabeling procedure as described 
above. After antibody binding, the microsomes were recovered by sedimen- 
tation in the Eppendorf centrifuge and resuspended in the protein A-gold 
conjugate suspension by gentle tapping. After incubation at room tempera- 
ture for 2.5 h, followed by washing with PBS (eight times for 2 min), the 
microsomes were refixed with 2% glutaraldehyde in 0.1 M  sodium phos- 
phate buffer (pH 7.4) for 2 h or overnight, washed with the same buffer (3 
x  10 rain), and fixed with 1%  OsO4 in 0.1  M  sodium cacodylate buffer 
(pH 7.4) for 1 h. Sections of epon-embedded  material were stained with ura- 
nyl acetate and lead citrate and viewed with a Philips 301 electron micro- 
scope at 80 kV. 
Quantitation of  lmmunogold Labeling 
of  Rat Liver Rough Microsomes 
The perimeters of rough microsomes and the numbers of gold particles on 
cross sections of ribosome-bearing membranes were measured on electron 
micrographs of randomly chosen fields at a final magnification of 62,500 
and recorded using a Hipad digitizer pad (Bausch and Lomb, Inc., Roches- 
ter,  NY)  and  a  stereological analysis program  (Black and  Cornacchia, 
1986). For each antibody tested a total rough microsomal membrane length 
of 30 pm, obtained from "~50 ribosome-bearing vesicles was measured. 
The labeling density (Table II) is expressed as the number of gold particles 
per micrometer of membrane. 
Results 
Fifteen  peptides  that  represent  different  segments  of the 
P-450 polypeptide were synthesized by standard procedures 
(Merrifield, 1963) and injected into rabbits to obtain antibod- 
ies specific for different sites in the P-450 molecule (Frey et 
al., 1985). The peptides and the antibodies to them are desig- 
nated with consecutive numbers (1-15) according to the posi- 
tion of the peptide along the P-450 polypeptide, beginning 
at the amino terminal end (Fig.  1). Three of the peptides (1, 
8, and 12, corresponding to residues 1-31, 173-184, and 290- 
302, respectively), contain portions of the main hydrophobic 
domains in the P-450 polypeptide whereas five others (2, 7, 
9, 11, and 13) represent largely hydrophilic segments adjacent 
to those hydrophobic domains (Fig.  1). Peptide 2 (residues 
24-38)  partially  overlaps with peptide  1 and contains  the 
hydrophilic sequence immediately adjacent to the amino ter- 
minal hydrophobic domain within peptide 1. Of the remain- 
ing seven peptides,  five represent  regions interspersed be- 
tween  other  segments  along  the  first  half  of the  P-450 
molecule (3 [40-48], 4 [61-72],  5 [93-98], 6 [108-116], and 
10 [211-233]), and two correspond to hydrophilic regions in 
the  COOH-terminal  half  of the  polypeptide  (14  and  15 
[residues 318-392 and 398-408,  respectively]). 
In a previous study (Frey et al.,  1985), these site-specific 
antipeptide antibodies were employed to localize function- 
ally important regions of the P-450 molecule that participate 
in substrate binding or in the interaction with the NADPH 
cytochrome P-450 reductase, and to demonstrate the conser- 
vation of specific domains of the polypeptide among different 
P-450 isozymes. These antibodies were now used to study 
the topology of the P-450 polypeptide with respect to the 
phospholipid bilayer in the ER membrane. 
The capacity of the antipeptide antibodies to recognize an- 
tigenic sites exposed on the surface of the P-450 PB molecule 
was measured in an ELISA employing chromatographically 
pure cytochrome P-450 and antibodies purified by affinity 
chromatography to the corresponding peptide. Except for an- 
tibodies to peptide 14, which showed no binding,  and anti- 
bodies to peptide 8, which bound very weakly, it was found 
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Figure 2.  Reactivity  of the  antipeptide  antibodies  to  purified 
cytochrome P-450 PB. The binding of  each antibody to immobilized 
cytochrome P-450 was measured in an ELISA test (see Materials 
and Methods). The numbers in the abscissa identify the rabbit an- 
tipeptide antibodies and the adsorbance values in the ordinate cor- 
respond to the mount of each antibody bound to the cytochrome 
P-450, determined from the color reaction yielded by the peroxi- 
dase-conjugated goat anti-rabbit second antibody. The brackets on 
the right ordinate define the system used to grade the binding. The 
ability of each antipeptide antibody to bind to P450 was graded as 
follows: -, <9.15 ,'1450 (not significant);  +,  0.15-0.3 A4o5; ++, 
0.3-0.6.4405; +++, >0.6 A4o5. 
that all other antibodies recognized the intact P-450 molecule 
(Fig. 2, Table I). To determine the extent to which the anti- 
genic sites for these antibodies correspond to portions of the 
P-450 molecule exposed on the surface of  the ER membrane, 
the binding of each antibody, labeled with mI, to intact rat 
liver rough microsomes was measured. In this assay, after in- 
cubation with the labeled antibodies, the microsomes were 
recovered by sedimentation through a heavy sucrose cushion 
containing a high salt concentration. The highest levels of 
saturable binding were obtained with antibodies to peptides 
4, 6, 7, and 15 (Fig. 3, Table I). All other antibodies showed 
lower, yet significant (at least twofold over background) lev- 
els of binding except antipeptide 14, which behaved like the 
pre-immune serum and was, therefore, used as a control in 
all other experiments.  The specificity of the binding was 
demonstrated by the fact that antibody preparations treated 
with the respective peptide antigens to preadsorb the specific 
IgGs  showed only background levels of binding to rough 
microsomes  (see  Fig.  3  for antipeptide  7  preadsorbed). 
These observations strongly suggest that the antigenic sites 
recognized in the P-450 molecule by antipeptide antibodies 
4, 6, 7, and 15 are directly accessible on the cytoplasmic face 
of the ER membrane.  The fact that some antibodies gave 
lower levels of binding to intact microsomes than expected 
from their capacity to bind to the purified P-450 molecule in 
the ELISA test (Table I, e.g. 1, 3, 5, and 10) raised the possi- 
bility that the corresponding antigenic sites are luminally lo- 
cated or at least partially embedded in the lipid bilayer. Al- 
ternatively, such sites may be exposed on the cytoplasmic 
surface of the microsomes but could be sterically hindered 
from the antibodies by other ER membrane proteins. 
It should be noted that even the highest level of antibody 
binding measured in this test (20 pmol of IgG/ttg of micro- 
somal protein at an input of 75 pmol) represents only a small 
fraction of  the number of binding sites theoretically available 
Table L Summary of  Data on the Binding of  the 
Antipeptide Antibodies to Purified Cytochrome P-450 and 
to Rough Microsomes 
Antipeptide  Binding to  Binding to RM 
antibody  purified 
No.*  P-450 PB*  [125I]IgG§  EM immunocytochemistry 
1  (1-31)  +++  +  (+) 
2 (24-38)  ++  +  ++ 
3 (40--48)  +++  +  + 
4 (61-72)  +++  +++  +++ 
5 (93-98)  +++  +  (+) 
6 (108-116)  +++  +++  +++ 
7 (122-131)  ++  +++  +++ 
8 (173-184)  +  +  (+) 
9 (186-193)  ++  +  +++ 
10 (211-223)  +++  +  + 
11 (225-232)  +++  ++  +++ 
12 (290-302)  ++  +  + 
13 (315-323)  ++  +  +++ 
14 (381-392)  -  -  - 
15 (398-408)  +++  ++  +++ 
The density of labeling (gold particles per micrometer of microsome perimeter) 
was measured  on micrographs  of rough microsomes  processed  by the  im- 
munogold technique. The grading system (from -  to +++) is described in the 
legend to Table II. 
* The numbers,  1-15,  assigned to the different antipeptide antibodies are the 
same used to designate the peptides that served as antigens.  The numbers in 
parentheses correspond to the amino acid residues that define the position of 
the peptides within the sequence of cytochrome P-450 PB-4 (see also Fig.  1). 
* The binding determined by the ELISA test was graded from -  to +++, as 
indicated in the legend to Fig.  2. 
§ The binding of mI-labeled antipeptide IgGs to rat liver rough microsomes 
was quantitated from the data in Fig. 3, measured at a 75 pmol of IgG. It is 
indicated as follows:  -,  <3 pmol t2sI IgG/mg RM;  +,  3-6 pmol/mg; ++, 
6-12 pmol/mg;  +++, >12 pmol/mg. 
in the microsomes (1.1 nmol P-450/mg microsomal protein). 
This is likely to reflect, at least in part, the loss of weakly 
bound antibody molecules during the centrifugation of the 
microsomes through the sucrose cushion containing high salt 
that had to be employed to separate them from the unbound 
antibodies. It is also possible that within the native P-450 
molecule, polypeptide segments bearing antigenic sites can 
attain several conformations, only some of which may be 
recognized by the antibodies (Shinnick et al.,  1983). 
An immunoelectron microscopic approach was  used to 
ascertain more directly whether each epitope in the cyto- 
chrome P-450 molecule recognized by the antibodies was ex- 
posed on the cytoplasmic or the luminal side of the ER mem- 
brane. Rat liver rough microsomes obtained from PB-treated 
animals were first incubated with the antipeptide antibody 
and  subsequently  with  the  protein  A-gold  conjugate that 
served as an electron dense marker. In electron micrographs, 
the gold particles are easily distinguished from the mem- 
brane-bound ribosomes that serve as a marker for the cyto- 
plasmic side of  the membrane. In intact microsomal vesicles, 
the antibodies and the gold particles have access only to the 
cytoplasmic surface of the membranes.  Rough microsome 
preparations, however, always contain small numbers of rup- 
tured or inverted vesicles and in these cases the luminal side 
of the membrane is accessible to the antibodies and the gold 
particles. 
Intense labeling of the  cytoplasmic membrane  surfaces 
was obtained with antipeptide antibodies 2, 4, 6, 7, 9, 11, 13, 
and 15 (Fig. 4, Tables I and 1I). Interestingly, some of these 
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Figure 3. Binding of mSI-labeled anti-P-450 peptide antibodies to 
rough microsomes from the livers of PB-treated rats. Aliquots of 
suspensions of rough microsomes from the livers of control or PB- 
treated rats were incubated with the individual mI-labeled IgGs 
(as indicated in Materials and Methods). The numbers (1 to 15) next 
to each curve are those assigned to the respective antipeptide anti- 
body (see Figs. 1 and 7). The arrow on each abscissa (75 pmol) in- 
dicates the IgG concentration used to compare the binding of  differ- 
ent antibodies. The symbols are used to differentiate anti-peptide 
antibodies in each panel. 
Table II. Labeling Density of  Rat Liver Rough Microsomes 
Incubated with Different Antipeptide Antibodies and 
Protein A-Gold* 
Antibody~.:  Density§  Scorell 
Gold particles/#m 
Pre-immune  0.6  - 
Preabsorbed anti-7  0.3  - 
Anti-P-450 PB  16.6  +++ 
1  0.8  (+) 
2  2.5  ++ 
3  1.8  + 
4  5.0  +++ 
5  0.9  (+) 
6  11.2  +++ 
7  10.9  +++ 
8  0.9  (+) 
9  9.1  +++ 
10  1.7  + 
11  11.5  +++ 
12  1.7  + 
13  11.2  +++ 
14  0.2  - 
15  9.4  +++ 
* Rough microsomes from the livers of PB-treated rats were incubated with 
the specific antibody and processed for the immunogold labeling technique as 
described in Materials and Methods. 
* The numbers, 1-15, assigned to the different antipeptide antibodies are those 
used to designate the peptides that served as antigens (see Fig.  1). 
§ The background labeling of 0.6 gold particles per micrometer, obtained for 
pre-immune IgG, was subtracted from all particle density values, except from 
the values obtained with "pre-immune IgG" and "preabsorbed anti-7." Density 
values listed are the average of two independent experiments using the same 
preparations of antibody and rough microsomes. Particle densities between ex- 
riments differed  at most by 35 %. 
e following scoring system was used for particle densities: -, <0.5; (+), 
0.5-1; +,  1-2; ++, 2--4; +++,  >4. 
antibodies (e.g., 9 and 13) had given only weak binding in 
the biochemical assay,  but the strong labeling they gave in 
the immunoelectron microscopy assay left no doubt as to 
their specificity and the cytoplasmic exposure of their re- 
spective antigenic domains. Very low labeling was obtained 
with antibody 8, and as expected, pre-immune serum and an- 
tipeptide 14 gave no significant labeling. Antibodies 1, 3, 5, 
10, and 12, which in the ELISA test bound efficiently to the 
purified P-450 but only poorly to the microsomes in the bio- 
chemical assay,  gave significant levels of binding (at least 2 
times above background,  Table 1I) in the immunoelectron 
microscopic assay,  and there was no doubt that their anti- 
genic sites were only present on the cytoplasmic face of the 
membrane. None of the antibodies bound to luminal mem- 
brane surfaces, which were clearly exposed in ruptured (Fig. 
4, arrows)  or inverted microsomes (Fig. 4, asterisks).  The 
specificity of the binding was clearly demonstrated by the 
fact that in all cases preincubation of  the antipeptide antibody 
with  intact microsomes to remove the  specific antibodies 
abolished  the binding  to the  subsequent test microsomes 
(e.g., Fig. 5). Moreover, no binding was observed to mito- 
chondria or plasma membrane fragments that contaminated 
the rough microsome samples (Figs. 4-6). 
The observations made with the site-specific antibodies 
were extended using antisera that were obtained from rabbits 
immunized with the complete P-450 polypeptide and had 
been characterized by determining their reactivity toward the 
various synthetic peptides (Frey et al.,  1985).  Six samples 
of these antisera were available and all of these recognized 
peptide 2.  One of them also recognized peptide 9 and an- 
other, peptide 15 (Frey et al., 1985). When the specific anti- 
bodies were removed from the anti P-450 antisera by adsorp- 
tion to the respective immobilized peptides,  however, the 
antisera still recognized the intact P-450 molecule. There- 
fore, the antisera also contained antibodies to P-450 epitopes 
not present in the repertoire of peptides used in this study. 
With all these antisera, exclusive labeling of the cytoplasmic 
surface of microsomal membranes was observed (Fig. 6), al- 
though it was clear that the luminal face in many ruptured 
microsomal vesicles was accessible to the antibodies.  The 
density of labeling of the cytoplasmic face obtained with the 
antisera raised against the complete P-450 was higher than 
that obtained with any of the antipeptide antibodies (Table 
II). These observations confirm those of other investigators 
(Matsuura et al., 1978, 1979, 1983) who, using antisera to the 
whole P-450 molecule, found no labeling of the luminal face 
of microsomal membranes. 
Discussion 
Although  a  rigorous determination of the transmembrane 
disposition of a membrane protein generally requires the use 
of macromolecular probes, such as antibodies and proteases, 
and nonpenetrating or selective labeling reagents, in recent 
De Lemos-Chiarandini et al. Topology of Cytochrome P-450  213 The Journal of Cell Biology, Volume 104,  1987  214 Figure 4. Immunoelectron microscopic localization of anti-P450-peptide antibodies bound to rough microsomes. After incubation with 
the affinity-purified antipeptide antibodies  (anti-1 to anti-7 in A and anti-8 to anti-15 in B) or with preimmune rabbit IgG (PI, first panel 
in  A), the rough microsomes were labeled with protein A-gold (10 nm) complexes and prepared for routine electron microscopy. The antipep- 
tide antibody used is indicated  by the number in the upper left-hand corner of each panel. Labeling densities  are scored  from -  (not 
significant) to + + +  (dense labeling), as explained in Tables I and II. The arrows point to ruptured microsomal vesicles, and the asterisks 
label inverted rough microsomes.  Note that the luminal sides of microsomal membranes are not labeled.  Membranes of organeUes con- 
taminating the microsomal preparations are also unlabeled (arrowheads).  Bars,  0.2 p.m. Figure 5. Specificity  of the binding of antipeptide antibodies to the 
cytoplasmic surface of rat liver microsomes. The rough micro- 
somes were incubated with the affinity-purified  antipeptide 7 IgG 
(a), or with the supematant (b) obtained after the antipeptide  7 IgG 
was preincubated with rough microsomes to preadsorb the specific 
IgGs. Note that whereas the mitochondrial membrane (M) is unla- 
beled,  the cytoplasmic surface of the rough microsomes (a)  is 
densely labeled, and that preincubation with rough microsomes 
abolishes the binding (b). Bar, 0.2 gm. 
years the  availability of complete  primary  sequences  for 
numerous membrane proteins has allowed tentative predic- 
tions  of their transmembrane  disposition  to  be  made on 
the basis of hydropathy plots (Hopp and Woods, 1981; Kyte 
and Doolittle, 1982). Thus, several authors have suggested, 
assuming that  intra-  and  interhelical  ion pairs  neutralize 
charges in putative transmembrane domains, that the rabbit 
PB-inducible cytochrome P-450  polypeptide traverses  the 
rhembrane at least eight times (Heinemann and Ozols, 1982; 
Tarr et al., 1983; Ozols et al., 1985). The hydropathy profile 
of the rat liver P-450  PB-4 studied here closely resembles 
that of the major PB-induced form (isozyme 2) present in 
rabbit liver, and corresponding putative membrane-spanning 
domains in the rat and rabbit P-450s are easily identified, al- 
though they vary somewhat in hydrophobicity and precise 
length (Fig. 7). In the rat P-450 PB-4, the four polar regions 
that would join the transmembrane domains on the luminal 
side of the ER membrane (Tarr et al., 1983) are represented 
in peptides 2, 6, 9, 12, 13, and 15. We have shown, however, 
both through the binding of radiolabeled antibodies and, 
more  convincingly, by  immunoelectron microscopy,  that 
these peptides are accessible to antibodies in intact micro- 
somes and are therefore exposed on the cytoplasmic surface 
of the membrane, which is contrary to the models proposed 
for the transmembrane disposition of the rabbit P-450.  An 
analysis of the hydrophobicity and length of the postulated 
eight transmembrane domains of the rabbit P-450  isozyme 
2 (Tarr et ai., 1983) shows, in fact, that only the first and fifth 
of these domains comprise more than 17 amino acids and 
have mean hydrophobicities of at least  1.6, which are re- 
garded as minimum conditions necessary to provide for the 
stable  association of a  polypeptide with the lipid bilayer 
(Kyte and Doolittle, 1982). Further evidence against the ex- 
istence of multiple transmembrane domains is provided by 
the fact that the hydrophobic photoactivatable reagent 3-(tri- 
fluoromethyl)3-(m['~I]-iodopbenyl)  diazirine, when applied 
to rat liver microsomes, labeled the putative substrate bind- 
ing site of P-450  PB-4 but none of the putative transmem- 
brahe domains (Frey et al.,  1986). 
We found that none of  the 15 antipeptide antibodies against 
various portions of P-450 showed any binding to the luminal 
face of microsomal membranes and that many showed strong 
binding to the cytoplasmic surface. These results are, there- 
fore, consistent with a model in which nearly the entire pro- 
tein is exposed on the cytoplasmic surface of the ER mem- 
brane.  Indeed,  on  the  basis  of  the  fact  that  P-450  is 
synthesized in membrane-bound ribosomes and contains at 
its amino terminus an extremely hydrophobic segment that 
is retained in the mature protein (Bar-Nun et al.,  1980) we 
have previously suggested that this segment functions as a 
signal that initiates cotranslational insertion of the protein 
into the membrane,  but also halts translocation of down- 
stream sequences and serves as a permanent anchor for the 
protein. In this regard, the behavior of the antibodies to pep- 
tide 1 (residues  1-31) and peptide 2 (residues 24-38)  is of 
particular interest. Antibodies to peptide 1 bound strongly 
to the purified P-450, but very weakly to the cytoplasmic sur- 
face of the rough microsomes, and not at all to the luminal 
side of the microsomal membranes. On the other hand, anti- 
bodies to peptide 2, which partially overlaps with peptide 1, 
clearly labeled the surface of intact microsomes. Thus, the 
very weak binding of antipeptide 1 antibodies to the rough 
microsomes may represent the recognition of epitopes that 
are also present in peptide 2 (residues 24-31).  These data are 
therefore consistent with a disposition of P-450 in which the 
amino terminal segment of the molecule (including approxi- 
mately the first 20 residues) is embedded in the phospholipid 
bilayer and the immediately following segment is exposed on 
the cytoplasmic side. 
We cannot establish,  however,  whether the charged ex- 
treme amino terminus of P-450 is located on the luminal side 
and therefore the first 20 residues completely span the ER 
The Journal of Cell Biology,  Volume  104, 1987  216 Figure 6. Binding of  antibodies raised to the purified P-450 PB. The rough microsomes were incubated with a rabbit anti-P-450 PB antibody 
raised against the complete P-450 polypeptide. Labeling occurs exclusively on the cytoplasmic surfaces to which ribosomes are bound. 
The arrows point to the luminal surfaces of ruptured rough microsomal vesicles, which are free of label, as is the surface of contaminating 
mitochondrial membranes (M).  Similar results were obtained with all six different antisera. Bar, 0.2 ~tm. 
membrane, or whether this portion of the polypeptide forms 
a  loop within the membrane and therefore does not com- 
pletely traverse the  bilayer.  A  loop  configuration for the 
amino terminal region of P-450 is consistent with the pro- 
posal  (Bar-Nun  et al.,  1980)  that  during  synthesis of the 
polypeptide this portion of the molecule functions as a non- 
cleavable insertion signal,  since it is thought that in many 
cases insertion signals assume a loop disposition (Inouye and 
Halegoua, 1980; Steiner et al.,  1980; Sabatini et al.,  1982). 
On the other hand,  it is  clear that  the insertion signal  in 
rhodopsin, which is near but not at the extreme amino termi- 
nus, also displays combined insertion and halt transfer prop- 
erties,  and does not adopt a  loop disposition.  This signal 
traverses the membrane only once, since the region of rho- 
dopsin preceding the signal  is exposed on the exoplasmic 
face of the photoreceptor membrane, which corresponds to 
the luminal side of the ER (Friedlander and Blobel,  1985). 
In  a  configuration analogous  to that  of rhodopsin,  P-450 
would, therefore, have its extreme amino terminus exposed 
on the luminal side of the ER membrane. 
A second segment of the P-450 polypeptide, which extends 
from residues 168 to 185 and is partially contained in peptide 
8, could, from its average hydrophobicity and length, also be 
considered as a potential membrane-embedded domain. Un- 
fortunately, antipeptide  8  antibodies  bound weakly to the 
purified P-450 polypeptide and gave only slightly higher than 
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Figure 7. Conservation of hydrophobic and hydrophilic regions of 
the rat and rabbit liver PB-inducible P-450s. The hydropathy plots 
shown correspond to the sequences of the rat liver cytochrome 
P-450 PB-4 (A) (Fujii-Kuriyama et al., 1982) and the PB-inducible 
rabbit liver isozyme 2 (B) (Heinemann et al.,  1982). Polypeptide 
segments of high average hydrophobicity are represented by peaks 
above the mid-line and those of  prevalent hydrophilicity by troughs. 
The segments within the sequence of P-450 PB-4 that correspond 
to the peptides used to prepare the site-specific antibodies are indi- 
cated by bars at the top of the graph. The numbers near the bars 
identify the peptides (see also Fig. 1). The relative reactivity of the 
antipeptide antibodies against P-450 epitopes exposed in rough 
microsomes, determined by immunoelectron microscopy, is indi- 
cated. These range from -  (not significant) to +++ (dense label- 
ing) (see Tables I and II). 
background binding to the intact microsomes. We cannot, 
therefore, directly establish whether this portion of the mole- 
cule is embedded in the membrane. If this were the case, 
however, the polypeptide could not traverse the membrane 
completely, since antipeptide antibodies  corresponding to 
both the preceding and following portions of the P-450 mole- 
cule intensely labeled the cytoplasmic microsomal surface. 
We must  therefore conclude that  if the  segment between 
residues 168 and 185 is membrane embedded, it too must as- 
sume a loop disposition. In addition, it is worth noting that 
an analysis of the primary sequence of P-450 in terms of  pos- 
sible  amphipathic  secondary  structure  (Schiffer and  Ed- 
mundson,  1967; Kaiser and Ktzdy, 1984) suggests that, al- 
though less hydrophobic in its overall character, the portion 
of the P-450 PB-4 molecule that extends from amino acids 
206 and 224 (represented in peptide 10) could form an am- 
phipathic helix.  This segment could therefore interact di- 
rectly with the ER membrane and be partially embedded in 
the lipid bilayer. Such disposition would be consistent with 
the fact that antibodies to peptide 10 reacted weakly with in- 
tact microsomes but bound intensely to purified P-450. 
Previous studies have shown that several of the antipeptide 
antibodies utilized here (4, 6, and 7) inhibit the function of 
P-450 as a mixed function oxidase when added to a system 
in which the P-450 molecule and its reductase are incorpo- 
rated together in lipid micelles (Frey et al., 1985). This inhi- 
bition most likely reflects antibody-induced changes in the 
substrate-binding site of P-450 or an interference with the ca- 
pacity of P-450 to interact with its reductase. Since the reduc- 
tase is almost totally exposed on the cytoplasmic side of the 
membrane, these observations were consistent with the sug- 
gestion, now confirmed directly, that the antigenic sites in 
peptides 4, 6, and 7 are exposed on the cytoplasmic side of 
the ER membrane. Similar considerations suggest that cys- 
teine residue 436,  which  is thought to provide the heme- 
binding site in cytochrome P-450 (Gotoh et al., 1983; Ades- 
nik and Atchison, 1985), is also exposed on the cytoplasmic 
side of  the membrane since during electron transfer the heme 
interacts  directly with  the  flavine mononucleotide in  the 
reductase, which must be exposed on that side of the mem- 
brane. 
The results presented here, therefore, provide strong sup- 
port for a model for the disposition of P-450 with respect to 
the lipid bilayer in which at least the portion of the molecule 
that follows the amino terminal putative insertion-stop trans- 
fer signal and extends to residue 168 is completely exposed 
on the cytoplasmic surface of  the ER. Even though it is possi- 
ble that other relatively uncharged segments of the polypep- 
tide (in particular the 168-185 segment and possibly the am- 
phipathic helical region in residues 206-224) also serve as 
additional anchoring domains, these could not fully traverse 
the ER membrane. 
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